Replies to post #82543 on Ayala Pharmaceuticals Inc (ADXS)

[cdiddy01]

It’s deal or dilution. The longer it goes the more ppl bet on dilution. Its really all that is left to consider here. Data too far off to save dilution.

I agree with this. Data is so far off and we're down here with the hyenas now. The mysterious HOT is the only other thing at this point that will get this going. AXAL deal may come, but won't be the home run hitter it was originally thought to be.

This stock has been utterly decimated so I don't have much more to lose... hah

[polaco3us]

Their only source of risk is HOT, AMGEN already owns NEO and as far as I see it ... on paper is not a bad platform vs the competition.

If NEO data is good, I see at most one milestone payment and then a buyout.
The point being ADXS is one of the few companies in this space developing both solutions(NEO and HOT) and the best move for AMGEN if they see good NEO data is to get both potential solutions at once for a really good price.

Go Zen
Cheers